Shattuck Labs (STTK) Share-based Compensation (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Share-based Compensation of $262000.0 for Q1 2026, down 84.78% year-over-year from $1.7 million in Q1 2025, and down 96.22% quarter-over-quarter from $6.9 million in Q4 2025.
Analysis
Shattuck Labs (STTK) Share-based Compensation (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Share-based Compensation for 8 consecutive years, with $262000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 84.78% year-over-year to $262000.0; the TTM figure through Mar 2026 stood at $5.5 million (up 1927.06% YoY), while the FY2025 annual figure was $7.0 million, up 1451.0% from the prior year.
- Share-based Compensation declined to $262000.0 in Q1 2026 per STTK's latest filing, from $6.9 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.2 million in Q3 2024 and bottomed at -$7.2 million in Q4 2024.
- Historically, Share-based Compensation has averaged $1.5 million across 5 years, with a median of $1.8 million in 2025.
- On a YoY basis, Share-based Compensation climbed as much as 6246.15% in 2024 and fell as far as 205.0% in 2024.
- Shattuck Labs' Share-based Compensation stood at $2.9 million in 2022, then surged by 134.3% to $6.9 million in 2023, then tumbled by 205.0% to -$7.2 million in 2024, then soared by 195.65% to $6.9 million in 2025, then plunged by 96.22% to $262000.0 in 2026.
- Business Quant data shows STTK's Share-based Compensation at $262000.0 in Q1 2026, $6.9 million in Q4 2025, and -$3.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 120.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 277.20 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 137.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - | 2.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.73 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.78 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 2.95 Mn |
| Dec 31, 2021 | 1.22 Mn |
| Sep 30, 2021 | 1.34 Mn |